1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, June 2016 (p20)

Biotechnology Analysis & Statistics in the United States, June 2016 (p20)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

571-600 of about 2 100 reports

Purchase Reports From Reputable Market Research Publishers

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

  • Industries : Biological Therapy, Therapy, Biotechnology, Pathology, Cancer, Pharmaceutical
  • Countries : United States
P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016

P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘P-Selectin (Granule ...

  • Industries : Therapy, Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : United States, World
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme ...

  • Industries : Cancer, Pathology
  • Countries : United States
Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016

Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Proprotein ...

  • Industries : Therapy, Pharmaceutical, Chronic Disease, Pathology
  • Countries : United States
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 ...

  • Industries : Pathology, Cancer, Therapy, Pharmaceutical
  • Countries : United States
Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • June 2016
  • by Global Markets Direct

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016’, provides an overview ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World, Japan
Acute Lung Injury - Pipeline Review, H1 2016

Acute Lung Injury - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • June 2016
  • by Global Markets Direct

Acute Lung Injury - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Lung Injury - Pipeline Review, H1 2016’, provides an overview of the Acute Lung Injury pipeline landscape. The ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016

BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • June 2016
  • by Global Markets Direct

BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016’, provides an overview of the BioMarin ...

  • Industries : Pharmaceutical, Research and Development
  • Countries : United States
XOMA Corporation - Product Pipeline Review - 2016

XOMA Corporation - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • June 2016
  • by Global Markets Direct

XOMA Corporation - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘XOMA Corporation - Product Pipeline Review - 2016’, provides an overview of the XOMA Corporation’s pharmaceutical ...

  • Industries : Therapy, Pathology, Research and Development
  • Countries : United States, World
Burkholderia Infections - Pipeline Review, H1 2016

Burkholderia Infections - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • June 2016
  • by Global Markets Direct

Burkholderia Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Burkholderia Infections - Pipeline Review, H1 2016’, provides an overview of the Burkholderia Infections pipeline ...

  • Industries : Pathology, Therapy, Healthcare, Pharmaceutical
  • Countries : United States
Liver Cancer - Pipeline Review, H1 2016

Liver Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape. The report provides ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 ...

  • Industries : Cancer, Therapy, Pathology, Biotechnology, Oncology, Biopharmaceutical, Pharmaceutical
  • Countries : United States
CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Biopharmaceutical, Biological Therapy, Pathology, Therapy, Biotechnology, Cancer
  • Countries : United States
Catenin Beta-1 (Beta Catenin or CTNNB1) - Pipeline Review, H1 2016

Catenin Beta-1 (Beta Catenin or CTNNB1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Catenin Beta-1 (Beta Catenin or CTNNB1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Catenin Beta-1 (Beta Catenin or CTNNB1) - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Cancer, Therapy
  • Countries : World, United States
Global Protein Ingredients market 2016-2020

Global Protein Ingredients market 2016-2020

  • $ 2 500
  • Industry report
  • June 2016
  • by Infiniti Research Limited

About Protein Ingredients Protein ingredients are protein-rich materials used as ingredients in food, beverages, and feed products such as dietary supplements, sports nutrition products, bakery products, ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe, United States
Stellar Biotechnologies, Inc.

Stellar Biotechnologies, Inc.

  • $ 99
  • Company report
  • June 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Stellar Biotechnologies, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biotechnology
  • Countries : United States, World
Chr Hansen in Ingredients (World)

Chr Hansen in Ingredients (World)

  • $ 570
  • Company report
  • June 2016
  • by Euromonitor International

Chr Hansen is a global market leader in cultures, enzymes and natural colours. After five years of control by a private equity firm, the newly streamlined business returned to public ownership and has ...

  • Industries : Dairy Products, Food
  • Countries : World, Europe, Asia, China, United States
Cardiac Markers

Cardiac Markers

  • $ 1 995
  • Industry report
  • June 2016
  • by Kalorama Information

Cardiac Markers provides market assessment, estimate and competitive analysis for tests for cardiovascular disease (CVD) that use biomarkers, including: - Worldwide Cardiovascular Disease Biomarkers Diagnostic ...

  • Industries : Chronic Disease, Pathology, In Vitro Diagnostics
  • Countries : United States
Streptococcal Infections - Pipeline Review, H1 2016

Streptococcal Infections - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • June 2016
  • by Global Markets Direct

Streptococcal Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Streptococcal Infections - Pipeline Review, H1 2016’, provides an overview of the Streptococcal Infections pipeline ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Lassa Fever - Pipeline Review, H1 2016

Lassa Fever - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • June 2016
  • by Global Markets Direct

Lassa Fever - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Lassa Fever - Pipeline Review, H1 2016’, provides an overview of the Lassa Fever pipeline landscape. The report provides ...

  • Industries : Pathology
  • Countries : United States
C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (C-C CKR-5 ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical
  • Countries : United States
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) ...

  • Industries : Pathology, Biological Therapy, Therapy, Biotechnology
  • Countries : United States
Dengue Fever - Pipeline Review, H1 2016

Dengue Fever - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • June 2016
  • by Global Markets Direct

Dengue Fever - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Dengue Fever - Pipeline Review, H1 2016’, provides an overview of the Dengue Fever pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Biopharmaceutical, Healthcare, Pharmaceutical, Biotechnology
  • Countries : United States, World
CytomX Therapeutics, Inc. - Product Pipeline Review - 2016

CytomX Therapeutics, Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Industry report
  • June 2016
  • by Global Markets Direct

CytomX Therapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘CytomX Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the CytomX Therapeutics, ...

  • Industries : Therapy, Research and Development, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Gaucher Disease - Pipeline Review, H1 2016

Gaucher Disease - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • June 2016
  • by Global Markets Direct

Gaucher Disease - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Gaucher Disease - Pipeline Review, H1 2016’, provides an overview of the Gaucher Disease pipeline landscape. The report ...

  • Industries : Pathology, Biopharmaceutical, Healthcare, Biotechnology, Therapy
  • Countries : United States, World
Glycoprotein 41 (gp41) - Pipeline Review, H1 2016

Glycoprotein 41 (gp41) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Glycoprotein 41 (gp41) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glycoprotein 41 (gp41) - Pipeline Review, H1 2016’, provides in depth analysis on Glycoprotein 41 (gp41) targeted ...

  • Industries : Therapy, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : France, United States, World
Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Tumor Necrosis Factor Recepto ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology, Pathology
  • Countries : United States
Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple ...

  • Industries : Cancer, Pathology
  • Countries : United States
C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Pathology
  • Countries : United States
Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • June 2016
  • by Global Markets Direct

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Chronic Disease, Healthcare
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.